Compounders Research Compare

Outset Medical, Inc.(OM)

Medical - Devices · San Jose, CA

$4.13+0.03 (+0.62%)

Delayed quote: Oct 6, 2026, 1:48 PM EDT

About Outset Medical, Inc.

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

San Jose, CA

310 employees

www.outsetmedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Leslie L. Trigg

View full financials

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T17:52:41.722Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:52:41.722Z.

Quote observation: 2026-10-06T17:48:14.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 76,471,676
Total debt · period ending 2026-06-30: 104,449,000
Cash · period ending 2026-06-30: 35,005,000
TTM operating EBITDA · period ending 2026-06-30: -62,617,000

FMP input reference: e005637c0728ee7719d987fd9d1ed1bb4b4a72c9577e4c0c1fad472fb0ddb1d0

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

OM EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

OM Competitors' EV/EBITDA Ratio

Outset Medical, Inc.

Current

Market Cap

$76.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Hyperfine, Inc.

Market Cap

$76.48M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SkinHealth Systems Inc.

Market Cap

$76.01M

EV/EBITDA Ratio

10.32x

TTM Avg

27.31x

3Y Avg

27.31x

5Y Avg

27.31x

Pulmonx Corporation

Market Cap

$77.08M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Sera Prognostics, Inc.

Market Cap

$77.72M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Neonc Technologies Holdings, Inc.

Market Cap

$79.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Inovio Pharmaceuticals, Inc.

Market Cap

$77.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Nutriband Inc.

Market Cap

$81.14M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Acrivon Therapeutics, Inc. Common Stock

Market Cap

$80.47M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Citius Oncology, Inc.

Market Cap

$80.84M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Outset Medical, Inc. (OM)	$76.47M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$76.48M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$76.01M	10.32x	27.31x	27.31x	27.31x
Pulmonx Corporation (LUNG)vs ›	$77.08M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$77.72M	N/A	N/A	N/A	N/A
Neonc Technologies Holdings, Inc. (NTHI)vs ›	$79.09M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$77.38M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$81.14M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$80.47M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$80.84M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics